STML - Stemline Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $11.07. This is a potential upside of $11.07 (0%) from yesterday's end of day stock price of $0.

Stemline Therapeutics's activity chart (see below) currently has 33 price targets and 28 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 11.79% with an average time for these price targets to be met of 101.43 days.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 05-May-2020. First documented stock forecast 29-Aug-2013.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12.5

$0.67 (5.66%)

4 years 6 months 16 days ago
(05-May-2020)

0/4 (0%)

$0.41 (3.39%)

Buy

$11

$-0.83 (-7.02%)

$20

4 years 6 months 17 days ago
(04-May-2020)

1/5 (20%)

$-1.11 (-9.17%)

623

Hold

$10

4 years 6 months 17 days ago
(04-May-2020)

1/2 (50%)

$6.26 (94.86%)

38

Buy

$9

$-2.83 (-23.92%)

$25

4 years 8 months 5 days ago
(16-Mar-2020)

1/8 (12.5%)

$4.94 (121.67%)

49

$23

$11.17 (94.42%)

$23

7 years 9 months 18 days ago
(03-Feb-2017)

0/4 (0%)

$16.45 (251.15%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is STML (Stemline Therapeutics) average time for price targets to be met?

On average it took 101.43 days on average for the stock forecasts to be realized with a an average price target met ratio 11.79

Which analyst has the current highest performing score on STML (Stemline Therapeutics) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the current lower performing score on STML (Stemline Therapeutics) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on STML (Stemline Therapeutics)?

David Nierengarten works at WEDBUSH and has 7 price targets and 6 ratings on STML

Which analyst is the currently most bullish on STML (Stemline Therapeutics)?

Joseph Pantginis with highest potential upside - $20.17

Which analyst is the currently most reserved on STML (Stemline Therapeutics)?

Joseph Catanzaro with lowest potential downside - -$2.83

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?